Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PSN-GK1 is a potent activator of glucokinase (EC50: 0.13 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | PSN-GK1 is a potent activator of glucokinase (EC50: 0.13 μM). |
In vivo | PSN-GK1 exhibits an excellent pharmacokinetic profile, with high oral bioavailability, in the rat. PSN-GK1 can markedly reduce blood glucose which accompanied by a trend toward increased pancreatic insulin release. PSN-GK1 engenders potent antihyperglycemic effects in diabetic rodents without causing hypoglycemia [1]. At 5 mM glucose, PSN-GK1 activates glucokinase (4.3-fold, EC50: 130 nM), increases MIN6 insulin secretion (26-fold, EC50: 267 nM) and 2-DG hepatocytic uptake (3-fold, EC50: 1 μM). In C57Bl/6 mice, PSN-GK1 reduces blood glucose at 1 and 10 mg/kg (by mouth), but insulin is increased significantly at only the higher dose. In hyperinsulinaemic 10-mM glucose clamps, PSN-GK1 increases2-DG incorporation into liver glycogen sixfold [2]. |
Molecular Weight | 438.54 |
Formula | C20H23FN2O4S2 |
CAS No. | 745051-61-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PSN-GK1 745051-61-0 Others PSNGK1 PSN GK1 PSN-GK-1 inhibitor inhibit